Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society
Email not displaying correctly? View it in your browser.
eNews May 2010 - National MS Society
FDA reviews Gilenia June 10

Read more about the studies
First oral disease modifier goes to FDA review panel

After accepting Gilenia (fingolimod) for priority review, the FDA advisory panel meets on June 10 to make a recommendation. Witnesses may include Dr. Patricia O’Looney of the Society’s Research & Clinical Programs — and people with MS who may testify to their need for more treatment options. If recommended for approval, Novartis may market Gilenia — the very first MS disease modifier in pill form — within the next six months.

Read more about the studies

Double your impact

 Find us on Facebook 

YouTube MySpace Twitter



Meet David Hafler

Dr. David Hafler wins MS research prize



Zurich2Venice International team, Zurich2Venice, honors World MS Day with grueling ride
Momentum Summer 2010 Kids get MS too

Momentum magazine covers pediatric MS in depth. Meet some very young MS veterans — and find out what researchers hope to learn. Six new Pediatric MS Centers of Excellence, funded by the Society’s Promise: 2010 campaign, offer expert supportive care.

Read the Summer issue of Momentum online.


Smoking and Epstein-Barr VirusSmoking pluss Epstein-Barr virus may increase risk
The combination of exposure to tobacco and EBV, the virus that causes mononucleosis, may substantially increase the risk of developing MS, new research suggests. By pooling data from three large-scale long-term studies, this novel study was able to look at interactions among several factors.

Learn more


World MS Day - May 26, 2010World MS Day is May 26
Join the global movement. End MS! Take action on World MS Day. 
Learn more

In the USA, we’re on a 10-week journey — filming stories of people who keep moving forward despite all that MS throws at them. This initiative
is supported in part by Novartis
Pharmaceuticals Corporation.
Watch the videos

This communication is partially sponsored through the generous support of Bayer HealthCare and Teva Pharmaceuticals, Inc.

Bayer HealthCare       Teva Pharmaceuticals, Inc.

More MS News
May 7: Consensus on stem-cell research published
April 28: New study of twins suggests environmental factors
Read more about these and other recent reports
Shop at the Society Store       Join a Walk MS Event       Join a Bike MS Event

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our Web site.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to . To ensure that you continue to receive our emails, please add us to your address book.